Menu

CME Corner

Active Programs

Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?

This activity, the first in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the practice of motivational interviewing (MI) and how it can help clinicians prompt patients to think about their diagnosis and therapeutic options. The management of MS is increasingly challenging due to the wide variation in the clinical course for each patient, an increas ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?

This activity, the second in a 3-part series focused on shared decision making and patient-centered care in MS, will examine the differences in MS disease-modifying therapies (DMT) and provide guidance for working together with patients to select appropriate first-line treatment. ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ANCC

Shared Decision Making at the Crossroads: Adjusting MS Therapy Next Question: When Is it Time to Adjust Therapy?

This activity, the third in a 3-part series focused on shared decision making and patient-centered care in MS, will examine how to assess outcomes of DMT therapy from both patient and clinician perspectives, as well as practical strategies for working with patients to adjust therapy when necessary. ...

  • i-Newsletter
  • ACCME
  • ANCC

Expired Programs

A Case Study in Monitoring and Managing Response and Resistance in CML

Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with tyrosine kinase inhibitors (TKIs) has dramatically improved 10-year overall survival for patients with CML from 20% to 80%-90%. To determine the best treatment approach for patients with CML, clinicians must thoroughly understand how to monitor treatment ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Achieving Optimal Outcomes in Patients With Inflammatory Bowel Disease

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on September 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. IBD is a chronic progressive inflammatory disorder of the GI tract, which includes Crohn’s disease (CD) and ulcerative colitis (UC). CD and UC ar ...

  • Online Presentation Online Presentation
  • ACCME

Current Best Practices in the Management of Castration-Resistant Prostate Cancer

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on April 22, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Among men in the United States, prostate cancer is the most common cancer and the second leading cause of cancer-related death. The recommended treat ...

  • Online Presentation Online Presentation
  • ACCME

Diagnosis of PsA: Achieving an Accurate Assessment

Approximately 30% to 40% of people with psoriasis will also develop psoriatic arthritis (PsA), a painful and potentially disfiguring condition that remains underdiagnosed. Symptoms include fatigue, joint inflammation, and potentially progressive joint damage. This activity will examine the considerations for assessment and diagnosis of PsA. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Direct-acting Oral Anticoagulants and Guideline Updates: Preventing Stroke in Older Adults with Atrial Fibrillation

A CPE-certified online monograph with highlights from the American Society of Consultant Pharmacists workshop. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 million people in the United States. AF is an independent risk factor for ischemic stroke severity, recurrence, and mortality. AF is a disease ...

  • e-Monograph e-Monograph
  • ACPE

Improving Outcomes in Psoriasis: Exceeding Treatment Goals and Patient Expectations

This activity will address the management of psoriasis, including setting psoriasis treatment goals and monitoring treatment response to determine when adjustments to therapy are needed; developing tailored, evidence-based treatment regimens for individual patients; engaging patients in shared decision making for improved patient satisfaction; and considering clinical advances while developing tre ...

  • Online Presentation Online Presentation
  • ACCME

Improving Patient Outcomes in Chronic Myeloid Leukemia: Monitoring and Managing Response and Resistance

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on October 29, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Chronic myeloid leukemia (CML) is a myeloproliferative disorder of the bone marrow, accounting for 15% of adult leukemias. Targeted therapy with ty ...

  • Online Presentation Online Presentation
  • ACCME

Improving Women's Health Outcomes in MS: A Multidisciplinary Approach

Multiple sclerosis (MS) is a chronic neurologic disorder with potential for substantial negative impact on quality of life. MS is nearly 3 times more common in women compared with men and is typically diagnosed between the ages of 20 and 50. Since the diagnosis and treatment of MS frequently occur during women’s reproductive years, clinicians often face questions about MS treatment as it relates t ...

  • Video Roundtable Video Roundtable
  • ACCME

Individualizing Treatment Plans for Older Adults with T2DM

Approximately 26% of adults over age 65 in the US (11.2 million people) have diabetes. This is a heterogeneous population that includes individuals residing independently in communities, in assisted living, and in skilled nursing facilities. Management of diabetes in older adults should be carefully tailored, taking into account these variables. All members of the care team, including physicians, ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Management of Psoriatic Disease: Care and Ongoing Monitoring

Psoriatic arthritis (PsA) is underdiagnosed and undermanaged in the United States, and comorbidities that are often associated with PsA are sometimes overlooked. Many patients with PsA experience a significant emotional and physical impact from this condition despite an increase in options for successful treatment. This activity will examine the importance of early recognition and the consideratio ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Opioid-Induced Constipation: Improving Outcomes With Individualized, Evidence-Based Treatment

This activity will review the safety and efficacy of available therapies to prevent and treat opioid-induced constipation. It will also examine strategies for optimizing treatment selection and adjusting therapy when necessary to help patients achieve their treatment goals and improve their overall quality of life. ...

  • Reach MD / podcast Reach MD / podcast
  • ACCME

Perspectives on the Care of Older Adults with T2DM: A Multidisciplinary Discussion

This activity features an engaging multidisciplinary faculty discussion about special considerations in the care of older adults with T2DM. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. This is a heterogeneous population that includes individuals residing independently in communities, in assisted livi ...

  • Video Roundtable Video Roundtable
  • ACCME
  • ACPE
  • ANCC

Preventing Stroke in Atrial Fibrillation

Individuals with atrial fibrillation (AF) have a 4 to 5 times greater risk for ischemic stroke and tend to experience more serious strokes than those without AF. Although most strokes related to AF could be prevented with appropriate anticoagulation therapy, many patients are not receiving it. The goal of this activity is to help clinicians evaluate and optimally manage stroke risk in their patien ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Progress Against Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia, and its diagnosis and management remain a challenge in clinical practice. An expanding body of research on the pathogenesis of IPF, however, is leading to the identification of new therapeutic targets, and best practices are evolving with the emergence of new data and new therapies. This activity, which featu ...

  • Video Roundtable Video Roundtable
  • ACCME

Stroke Prevention in Atrial Fibrillation: Current Evidence for Tailoring Antithrombotic Therapy

NOTE: This activity was presented as a live visiting faculty grand rounds series beginning on August 20, 2015. Participants who received credit for attending any of the live presentations are not eligible to receive credit for this online release. Nonvalvular atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice and afflicts more than 3 milli ...

  • Online Presentation Online Presentation
  • ACCME
  • ANCC

Targeting B-Cell Lymphomas: The Latest Updates in Therapies, Practice Strategies, and Clinical Research

The standards of care in treatment for non-Hodgkin lymphomas (NHL) are evolving as new therapies receive FDA approval and new evidence provides insight into optimal evidence-based approaches. Several key cellular pathways that drive malignant B-cell development have recently been identified and validated, leading to the development of therapies targeting these pathways. Agents targeting the B-cell ...

  • Online Presentation Online Presentation
  • ACCME

Team-Based Approaches to Enhancing Care for Older Adults With T2DM

A collaborative and engaged style of care planning generally provides the best results for patients. Physicians, NPs, PAs, pharmacists, nurses, and others who care for and support older adults with type 2 diabetes (T2DM) can be most effective working in a team, especially when managing individuals with multiple chronic problems. This activity examines the key features of a holistic, relationship-b ...

  • i-Newsletter i-Newsletter
  • ACCME
  • ACPE
  • ANCC

Team-Based Approaches to Help Older Adults With Type 2 Diabetes Achieve Individualized Glycemic Goals

A CPE-certified online monograph with highlights from the American Society of Consultant Pharmacists workshop. Many older adults with T2DM are experiencing negative health consequences that could be prevented or improved with optimal evidence-based care. The goal of this monograph is to help consultant and senior care pharmacists achieve greater competency in participating in team-based care a ...

  • e-Monograph e-Monograph
  • ACPE

Treatment Patterns in Family Medicine: Clinical Perspectives on Incretin-Based Therapies in the Management of T2DM

The management of type 2 diabetes mellitus (T2DM) remains a major clinical challenge as many patients continue to struggle with achieving therapeutic goals. The goal of this activity is to improve knowledge and competency among primary care clinicians with regard to addressing glycemic variability in patients with T2DM through optimal therapeutic management, with a particular focus on the optimal ...

  • i-Newsletter i-Newsletter
  • AAFP
  • AANP
  • AAPA

Updates in the Management of COPD: Comorbidities and COPD

This activity will help clinicians achieve greater competency in the management of COPD and its myriad comorbidities. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Diagnosis and Management

This activity will help clinicians achieve greater competency in accurately diagnosing COPD, assessing disease severity, and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. COPD is a slowly progressive respiratory disease characterized by airflow limitation that is not fully reversible. Manifestations of COPD include dyspnea, poor exercise t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Updates in the Management of COPD: Managing Exacerbations

This activity will help clinicians achieve greater competency in managing exacerbations of COPD and optimizing the use of nonpharmacologic and pharmacologic interventions in tailored COPD treatment plans. ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Optimize Glycemic Control

The management of T2DM remains a major challenge as many patients continue to struggle with achieving glycemic control. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, have been shown to be safe and effective in improving glycemic control. This activity will examine the use of GLP-1 receptor agonists in clinical practice, including long-t ...

  • Mobile + Online on QuantiaMD Mobile + Online on QuantiaMD
  • ACCME

Using GLP-1 Receptor Agonists to Reduce Cardiovascular Risk

The management of T2DM remains a major challenge as many patients continue to struggle with achieving therapeutic targets, including control of A1c levels, LDL cholesterol, and blood pressure. Glucagon-like peptide 1 (GLP-1) receptor agonists, one of the newer drug classes for the treatment of T2DM, may offer beneficial effects on cardiovascular risk factors. This activity will examine the use of ...

  • Mobile + Online on QuantiaMD
  • ACCME
Main Menu
EDITOR'S PICKS